Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 92 of 95, showing 5 Applications out of 474 total, starting on record 456, ending on 460

# Protocol No Study Title Investigator(s) & Site(s)

456.

ECCT/13/04/09   Short-course RPT/INH for latent TB in HIV-infected individuals
        Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection   
Principal Investigator(s)
1. Deborah C. Langat
Site(s) in Kenya
1. Kenya Medical Research Institute Walter Reed Project Clinical Research Centre (Kericho county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
 
View

457.

ECCT/08/06/01   PARTNERS PrEP
    Parallel Comparison of Tenofovir and Emtricitabine/tenofovir Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition within HIV-1 Discordant Couples   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
1. Kisumu site (Kisumu county)
 
View

458.

ECCT/13/04/04   Enteric Study
    A Randomized, Double-Blind, Clinical Trial Evaluating Three Single Dose Regimens with Loperamide for Treatment of Ambulatory Watery Travelers’ Diarrhea, and Azithromycin with and without Loperamide for Treatment of Ambulatory Dysentery/Febrile Diarrhea   
Principal Investigator(s)
1. CPT Brook A. Danboise
Site(s) in Kenya
British Army Training Unit, Kenya (BATUK)
 
View

459.

ECCT/11/10/01  
    A RANDOMIZED PHASE IIA TRIAL OF GEMCITABINE COMPARED WITH  BLEOMYCIN PLUS VINCRISTINE FOR TREATMENT OF KAPOSI’S SARCOMA IN PATIENTS ON COMBINATION ANTIRETROVIRAL THERAPY IN WESTERN KENYA.   
Principal Investigator(s)
1. NAFTALI WISINDI BUSAKHALA
Site(s) in Kenya
MOI UNIVERSITY CLINICAL RESEARCH SITE
 
View

460.

ECCT/12/04/02   Short-course RPT/INH for latent TB in HIV-infected individuals
    A5279: Phase III Clinical Trial of Ultra-Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals with Latent Tuberculosis Infection       
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
View